Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The sky is not falling after all

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Aug 31, 2021 10:23am

165 Views

Post# 33787449

RE:The sky is not falling after all

Personally I'm still disappointed with the CR at around 30%. In theory I think the CR should be much higher. I wonder if the bladder epithelium in the NR or PR patients is compromised somehow and so the bladder cells in the epithelium are not absorbing enough. This would mean a patient induced dosing issue. Darn. How are they going to figure that one out? GLTA.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario